You are continuing an iterative cross-model debate on an implementation-plan artifact.
This is round 2. You have seen your round-1 critique and Claude's revision. Your job now:
1. ESCALATE findings Claude did not adequately address.
2. DROP findings Claude addressed.
3. SURFACE NEW findings exposed by Claude's revision.
4. Decide if the debate has converged (no new findings, >=80% prior findings addressed).
Do NOT repeat findings unchanged. Either escalate, drop, or replace.

# CRITICAL: still a REPO-READ debate — keep verifying against the actual code

You are READ-ONLY inside the target repo. Continue to open referenced files to verify
claims; a repo-verified finding is worth far more than a speculative one. Claude's
revision proposes concrete moves (a thin `referee_triple` adapter; redefining A off
`guide_kd_efficiency`/`DE_stats`; constraining B to Th1/Th2; reading C from the CSV;
converting the disjoint hard-gate to a ranked novelty score). Where those moves make
claims about the repo, CHECK them. Specifically worth re-opening:
- `docs/perturbseq-qc_2026-07-07/pyzobot_referee.py` — is a HOP-3 disease-C filter really
  thin (does the exploded T3 table carry a usable `disease` column per gene)? Read the
  `t3_exploded` construction and the `_hop3` logic to confirm the adapter is small.
- `data/DE_stats.suppl_table.csv` and `data/guide_kd_efficiency.suppl_table.csv` headers —
  can A ("KD-gated significant regulators") actually be derived deterministically from
  these, or is a coefficient/significance column missing?
- `docs/perturbseq-qc_2026-07-07/pyzobot_referee_ranked_full.csv` — does it carry the
  columns needed to seed the A universe WITHOUT leaking answers (per F-009)?

# Framing question

Same as round 1: is the (now-revised) LBD proposer the shortest CORRECT path to a
receipt-backed, condition-specific NOVEL finding by July 13, holding up against the
actual repo? PLUS the round-2 tension Claude raises: after constraining A/B/C, is this
still a genuinely GENERATIVE LBD engine, or has it collapsed into a lookup/reranker of
the 457 already-scored genes? If the latter, is demoing the referee on 2-3 hand-built
disjoint triples (and dropping the proposer) the stronger submission? Take a position.

# Preserve-intent directive

The novel claim is "LBD as a QUESTION-GENERATION engine whose output is MANDATORILY
culled by a data-referee." Do not sand it into "just run LBD" or "just run the referee."
But you MAY legitimately argue the constrained substrate is too thin to be generative —
that is critiquing execution, not sanding the claim. Prefer "open question" over false
agreement.

# Round history

## Round 1 — Claude's position (summary)
The spec's reframe (LBD generates questions -> referee culls) is the moat; entities are
bounded by the dataset so the matrix is pandas-computable; referee reused unchanged for
v1; money shot = one disjoint-in-lit + data-supported + condition-specific triple. Claude
flagged four assumptions for verification: A-source CSVs, referee disease-specificity,
disjoint-gate feasibility, condition first-classness.

## Round 1 — Codex's findings (verbatim JSON)
{ROUND1_FINDINGS_JSON}

## Round 2 — Claude's revision (summary)
Claude ACCEPTS all nine findings (none rejected/deferred). Key moves: (F-001/F-005) add a
thin `referee_triple(A,B,C,condition)` adapter that filters HOP-3 to the exact C; drop
"referee unchanged" wording. (F-002) redefine A off `guide_kd_efficiency`+`DE_stats`;
ranked_full seeds A-universe only. (F-003) v1 B = Th1/Th2 only; aging/cytokine out of
scope. (F-004) reword "condition-specific" to name only the KD/effect/disease hops, not
HOP-2. (F-006) read the 14 diseases from the CSV; umbrella terms = context only, not
eligible C claims. (F-007) convert `ac_lit<=0` hard gate to a ranked novelty score + a
preflight ac_lit/ac_known histogram. (F-008) v1 = one co-mention source (Europe PMC) +
Open Targets, cached fixtures, generated-vs-culled counts as deliverable, protect demo
time. (F-009) ranked_full used for A-eligibility only, answer columns hidden.

# Claude's round 2 position (full text follows)

